Publication | Open Access
A06 Tri-complex Inhibitors of the Oncogenic, GTP-Bound Form of KRASG12C Overcome RTK-Mediated Escape Mechanisms and Drive Tumor Regressions in Preclinical Models of NSCLC
23
Citations
0
References
2020
Year
Gtp-bound FormDrive Tumor RegressionsOncogenic AgentReceptor Tyrosine KinaseA06 Tri-complex InhibitorsAnti-cancer AgentCell BiologySystems BiologyMedicineRadiation OncologyTumor Biology
No additional data available for this publication yet. Check back later!